▲ Peaking
Health
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
An experimental KRAS-targeted vaccine has shown safety and the ability to generate durable immune responses in individuals at high risk for pancreatic cancer.